Zobrazeno 1 - 10
of 2 252
pro vyhledávání: '"Superficial bladder cancer"'
Publikováno v:
Cancer Management and Research, Vol Volume 14, Pp 389-398 (2022)
Zhi-Jia Li,1 Da-Ya Wang,1 Zhi-Hu Liu2 1Department of Urology, Wenzhou Central Hospital, Wenzhou, Zhejiang, 325000, People’s Republic of China; 2Department of Urology, Bei Da Huang Industry Group General Hospital, Harbin, Heilongjiang, 150088, Peopl
Externí odkaz:
https://doaj.org/article/65c89b10dbe14d86972ab3183ba73f12
Autor:
Karavana SY, Ay Şenyiğit Z, Çalışkan Ç, Sevin G, İlem Özdemir D, Erzurumlu Y, Şen S, Baloğlu E
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 12, Pp 1959-1975 (2018)
Sinem Yaprak Karavana,1 Zeynep Ay Şenyiğit,2 Çağrı Çalışkan,3 Gülnur Sevin,4 Derya İlem Özdemir,2 Yalçın Erzurumlu,5 Sait Şen,6 Esra Baloğlu1 1Department of Pharmaceutical Technology, Faculty of Pharmacy, Ege University, Izmir, Turkey;
Externí odkaz:
https://doaj.org/article/86a55f3020404fb89dd8b64b9974f0e0
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 2, Pp 383-387 (2018)
We present a case in which neoadjuvant arterial infusion chemotherapy was effective in treating a large superficial bladder cancer. A 50-year-old male was admitted to the Kanazawa Medical Center with the complaint of dizziness. The patient exhibited
Externí odkaz:
https://doaj.org/article/8e6f036e20844e518c05f1a1294bb67d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Cancer Management and Research
Zhi-Jia Li,1 Da-Ya Wang,1 Zhi-Hu Liu2 1Department of Urology, Wenzhou Central Hospital, Wenzhou, Zhejiang, 325000, Peopleâs Republic of China; 2Department of Urology, Bei Da Huang Industry Group General Hospital, Harbin, Heilongjiang, 150088, Pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c97a7ed72841439ae4644ce76f052797
http://europepmc.org/articles/PMC8805739
http://europepmc.org/articles/PMC8805739
Autor:
Sumit Isharwal, Badrinath Konety
Publikováno v:
Indian Journal of Urology, Vol 31, Iss 4, Pp 289-296 (2015)
Introduction: Non-muscle invasive bladder cancer (NMIBC) comprises about 70% of all newly diagnosed bladder cancer, and includes tumors with stage Ta, T1 and carcinoma in situ (CIS.) Since, NMIBC patients with progression to muscle-invasive disease t
Externí odkaz:
https://doaj.org/article/1efb395ccd374651bffb6f5fa30ae8ba
Publikováno v:
Journal of the Egyptian Society of Parasitology. 51:417-422
This study evaluated the role of routine biopsy from the site of previously resected superficialbladder tumor three months following resection and intravesical BCG therapy in the presenceof negative urine cytology and cystoscopy. Thirty-two patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e84ecb1aabec1c04f57873621fd3ced
https://doi.org/10.21608/jesp.2021.193332
https://doi.org/10.21608/jesp.2021.193332
Publikováno v:
Infectious Disease Reports
Infectious Disease Reports, Vol 13, Iss 57, Pp 611-618 (2021)
Infectious Disease Reports, Vol 13, Iss 57, Pp 611-618 (2021)
Intra-vesical instillation of bacillus Calmette–Guérin (BCG) is an important treatment modality of superficial bladder cancer. It is usually well tolerated, although some adverse reactions can occur. One possible yet rare complication is granuloma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2566cbd0e090cb3307ba13f2e0cda6d
https://doi.org/10.3390/idr13030057
https://doi.org/10.3390/idr13030057
Autor:
Maria Tariq, Khalid Hussain, Munazza Yasmeen, Muhammad Asif, Farooq Malik, Attiq-ur-Rehman Khan
Publikováno v:
The Professional Medical Journal. 28:854-860
Objective: To compare the recurrence rate of superficial transitional cell carcinoma of urinary bladder using intravesical BCG and Mitomycin-C. Study Design: Randomized Controlled Trial. Setting: Urology Department, Teaching DHQ Hospital, Gujranwala.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3edd8afaae3287873bfc300f7bfe652f
https://doi.org/10.29309/tpmj/2021.28.06.4968
https://doi.org/10.29309/tpmj/2021.28.06.4968
Dendritic cells in blood and urine samples from bladder cancer patients undergoing BCG immunotherapy
Autor:
Raffaella Rossi, Miriam Lichtner, Francesco Iori, Angela Ermocida, Claudia Mascia, Fabio Mengoni, Ilaria Sauzullo, Danilo Dini, Claudio M. Mastroianni, Vincenzo Vullo
Publikováno v:
Archivio Italiano di Urologia e Andrologia, Vol 85, Iss 4, Pp 157-163 (2013)
Objectives: Immunotherapy with BCG (Bacille Calmette-Guérin) after transurethral resection of the bladder tumor represents a highly effective primary treatment for intermediate and high-risk superficial bladder cancer. The effectiveness of this ther
Externí odkaz:
https://doaj.org/article/e340c799624a4e12963790d0ee118ae4